900 TBio BFX 4101: a neoantigen prioritization pipeline for selected tumor-infiltrating lymphocyte therapy
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1797631088668966912 |
|---|---|
| author | Quanyuan He Christian E Laing Stewart E Abbot Tony Collins Meghan Verschoor Chantal G Martin Michael Ciancanelli |
| author_facet | Quanyuan He Christian E Laing Stewart E Abbot Tony Collins Meghan Verschoor Chantal G Martin Michael Ciancanelli |
| author_sort | Quanyuan He |
| collection | DOAJ |
| first_indexed | 2024-03-11T11:16:59Z |
| format | Article |
| id | doaj.art-e80b1838eef54884b25ce12716225732 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T11:16:59Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-e80b1838eef54884b25ce127162257322023-11-11T03:05:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0900900 TBio BFX 4101: a neoantigen prioritization pipeline for selected tumor-infiltrating lymphocyte therapyQuanyuan He0Christian E Laing1Stewart E Abbot2Tony Collins3Meghan Verschoor4Chantal G Martin5Michael Ciancanelli6Key Laboratory of Molecular Epidemiology of Hunan Province, School of Medicine, Hunan Normal University, Changsha, Hunan, China2Turnstone Biologics, Carlsbad, CA, USA3Turnstone Biologics, San Diego, CA, USA3Turnstone Biologics, San Diego, CA, USA4Turnstone Biologics, Sudbury, Canada5Turnstone Biologics, Ottawa, Canada3Turnstone Biologics, San Diego, CA, USA |
| spellingShingle | Quanyuan He Christian E Laing Stewart E Abbot Tony Collins Meghan Verschoor Chantal G Martin Michael Ciancanelli 900 TBio BFX 4101: a neoantigen prioritization pipeline for selected tumor-infiltrating lymphocyte therapy Journal for ImmunoTherapy of Cancer |
| title | 900 TBio BFX 4101: a neoantigen prioritization pipeline for selected tumor-infiltrating lymphocyte therapy |
| title_full | 900 TBio BFX 4101: a neoantigen prioritization pipeline for selected tumor-infiltrating lymphocyte therapy |
| title_fullStr | 900 TBio BFX 4101: a neoantigen prioritization pipeline for selected tumor-infiltrating lymphocyte therapy |
| title_full_unstemmed | 900 TBio BFX 4101: a neoantigen prioritization pipeline for selected tumor-infiltrating lymphocyte therapy |
| title_short | 900 TBio BFX 4101: a neoantigen prioritization pipeline for selected tumor-infiltrating lymphocyte therapy |
| title_sort | 900 tbio bfx 4101 a neoantigen prioritization pipeline for selected tumor infiltrating lymphocyte therapy |
| work_keys_str_mv | AT quanyuanhe 900tbiobfx4101aneoantigenprioritizationpipelineforselectedtumorinfiltratinglymphocytetherapy AT christianelaing 900tbiobfx4101aneoantigenprioritizationpipelineforselectedtumorinfiltratinglymphocytetherapy AT stewarteabbot 900tbiobfx4101aneoantigenprioritizationpipelineforselectedtumorinfiltratinglymphocytetherapy AT tonycollins 900tbiobfx4101aneoantigenprioritizationpipelineforselectedtumorinfiltratinglymphocytetherapy AT meghanverschoor 900tbiobfx4101aneoantigenprioritizationpipelineforselectedtumorinfiltratinglymphocytetherapy AT chantalgmartin 900tbiobfx4101aneoantigenprioritizationpipelineforselectedtumorinfiltratinglymphocytetherapy AT michaelciancanelli 900tbiobfx4101aneoantigenprioritizationpipelineforselectedtumorinfiltratinglymphocytetherapy |